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Accepted 8 January 2016Neural stem cells (NSCs) have the ability to self-renew and give rise to neurons and glial cells (astrocytes and
oligodendrocytes) in the mammalian central nervous system. This multipotency is acquired by NSCs during
development and is maintained throughout life. Proliferation, fate speciﬁcation, and maturation of NSCs are
regulated by both cell intrinsic and extrinsic factors. Epigenetic modiﬁcation is a representative intrinsic
factor, being involved in many biological aspects of central nervous system development and adult
neurogenesis through the regulation of NSC dynamics. In this review, we summarize recent progress in the
epigenetic regulation of NSC behavior in the embryonic and adult brain, with particular reference to DNA
methylation, histone modiﬁcation, and noncoding RNAs.
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Neural stem cells (NSCs) are deﬁned as cells that have the capacity
for self-renewal and differentiation into 3 cell types: neurons and 2
types of glial cells, astrocytes, and oligodendrocytes. Neurogenesis,
the process by which neurons are generated from NSCs, occurs not
only in the embryonic but also in the postnatal/adult brain.
Neurogenesis takes place in particular zones throughout organism's
lifespan and has been implicated in various brain functions, such as
learning and memory (Bond et al., 2015; Christian et al., 2014; Gotz
and Huttner, 2005; Greig et al., 2013; Hsieh and Eisch, 2010;
Kriegstein and Alvarez-Buylla, 2009; Lledo et al., 2006; Miller and
Gauthier, 2007; Ming and Song, 2011). Therefore, neurogenesis is an
important process for both brain development and brain function.
During embryonic brain development, NSCs show unique features
as they produce each type of cell in the brain. The onset of
neurogenesis and gliogenesis is spatiotemporally restricted in the
developing brain, in which NSCs generate each type of cell in a
developmental stage-dependent manner: neurons are produced ﬁrst,
followed by glial cells. This change in the differentiation capacity of
NSCs as development proceeds is tightly regulated through cooper-
ation between extracellular factors and epigenetic mechanisms. In
addition, NSCs that have been maintained until adulthood mainly
produce neurons, and this adult neurogenesis consists of multiple
steps. NSCs generate neurons via the production of transiently
amplifying neuronal precursor cells (NPCs) through asymmetrical
division. Thus, adult neurogenesis starts from the activation of NSCkashima).
Inc. This is an open access article uproliferation, which is followed by production of NPCs and their
differentiation into neurons. Moreover, newly generated neurons are
integrated into preexisting neuronal circuitry, thereby contributing to
brain functions. Survival andmaturation of newborn neurons are thus
also key steps for adult neurogenesis to occur properly. In addition to
embryonic neurogenesis, accumulating research in adult neurogen-
esis has been highlighting the importance of epigenetic regulation to
control these processes.
Epigenetics can be deﬁned as heritable inﬂuences on chromatin
and gene function that are not accompanied by a change in DNA
sequence in the progeny of cells or individuals (Allis et al., 2015). DNA
methylation, histone modiﬁcation, and noncoding RNAs are predom-
inant epigenetic factors and have been studied for the last 2 decades.
These studies have demonstrated that distinct epigenetic factors
communicate with each other and play an essential role for the
regulation of NSCs in collaboration with extracellular cues. In this
review, we introduce representative examples of epigenetic mecha-
nisms involved in the dynamics of embryonic and adult NSCs.
1.1. Epigenetic mechanisms regulating neurogenic and gliogenic
competence of NSCs during development
Although the 3 types of cells in the brain are generated from NSCs
during central nervous system (CNS) development, NSCs do not
initially have the potential to generate these cell types. NSCs acquire
this competence sequentially as development proceeds. After NSCs
expand their pool by self-renewing in early brain development, they
ﬁrst produce neurons, followed by astrocytes and oligodendrocytes
(Fig. 1). Many factors that induce NSC differentiation into each lineage
have been identiﬁed, including Wingless/int (Wnt, neurons)
(Hirabayashi et al., 2004; Muroyama et al., 2004; Zhou et al.,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Nakashima et al., 1999a,b; Namihira and Nakashima, 2013), and Sonic
hedgehog (Shh, oligodendrocytes) (Lu et al., 2000; Tekki-Kessaris et
al., 2001). Recent studies have indicated that the way in which NSCs
respond to these factors alters during development and that
epigenetic mechanisms restrict the responsiveness of NSCs to them
at each stage of development. This contributes to the sequential
production of neurons and glial cells during development. In this
section, we describe how NSCs sequentially acquire the competence
to generate cells in each lineage during development, focusing on the
epigenetic mechanisms in the order of histone modiﬁcation, DNA
methylation, and noncoding RNAs.
1.2. Histone modiﬁcation regulating differentiation of NSCs
The remodeling of chromatin structure via histonemodiﬁcations is
an important means of modulating gene expression. Chromatin is
composed of multiple nucleosomes, each consisting of 147 base pairs
of DNAwrapped around histone proteins. Single nucleosomes contain
2 copies of each histone variant: histone 2A, histone 2B, histone 3
(H3), and histone 4. The amino acid residues in the N-terminal tails of
histone proteins are subject to multiple posttranscriptional modiﬁca-
tions, including acetylation, methylation, phosphorylation, and
ubiquitination (Bernstein et al., 2007; Kouzarides, 2007; Margueron
and Reinberg, 2010; Ruthenburg et al., 2007; Tessarz and Kouzarides,
2014). Histone modiﬁcations affect the access of transcription factors
to their binding sites, thereby inﬂuencing gene activation and
repression. For instance, lysine methylation of histone tails is
associated with both activation and repression of gene expression;
the effect of histone methylation on gene expression differs according
to the position in the histone tail and the number of methylation in
the lysine residues. H3 methylation at lysine 4 (K4), K36, and K79Fig. 1. Schematic diagram of developmental stage-dependent NSC differentiation in the em
divisions, leading to the expansion of their pool. NSCs ﬁrst acquire the potential to differenti
cells from late to perinatal stages. Representative epigenetic regulators of NSCs during embry
proliferation of NSCs. →, promotion; ⊣, inhibition.leads to transcriptional activation, whereas H3 methylation at K9 and
K27 is associated with transcriptional silencing. Both neurogenic and
gliogenic gene promoters undergo various histone modiﬁcations,
which ensure the sequential production of each cell type at
appropriate stages of development.
Neuronal differentiation precedes glial differentiation of NSCs
during development, and NSCs terminate neuronal production
gradually as glial differentiation commences. The reduction of
neuronal differentiation results from a change in the responsiveness
of NSCs to Wnt/β-catenin signaling. Activation of Wnt/β-catenin
signaling induces neuronal differentiation during midgestation
(neurogenic phase) through up-regulation of the proneural basic
helix-loop-helix (bHLH) transcription factor neurogenin1 (Neurog1)
(Hirabayashi et al., 2004; Sun et al., 2001). However, Neurog1
expression is no longer induced in NSCs at late gestation, when
astrogliogenesis from NSCs begins, even when Wnt/β-catenin
signaling is activated. This different responsiveness of NSCs to Wnt/
β-catenin signaling at each developmental stage is attributed to a
change in histone modiﬁcation status on the Neurog1 promoter.
The polycomb group (PcG) complex catalyzes H3 K27 trimethyla-
tion (H3K27me3), leading to transient transcriptional repression
through alteration of local heterochromatin conﬁguration (Ng and
Gurdon, 2008; Ringrose and Paro, 2007). The PcG consists of 2
complexes, polycomb repressive complex 1 (PRC1) and polycomb
repressive complex 2 (PRC2). PRC2 is responsible for the initiation of
gene silencing by catalyzing H3K27me3, which provides a mark for
PRC1 to be recruited for gene silencing. PRC1 maintains H3K27me3
and takes part in compacting chromatin states (Cao and Zhang, 2004;
Shen et al., 2008).
One of the PRC2 components, enhancer of zeste 2 (Ezh2), an
enzyme responsible for H3K27me3, is highly expressed in NSCs in the
gliogenic phase and prevents Wnt signaling–mediated expression ofbryonic brain. During early embryonic stages, NSCs undergo self-renewing symmetric
ate into neurons at midgestation. They then acquire the ability to differentiate into glial
onic brain development are depicted. Semicircular arrows indicate the self-renewal and
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2009; Pereira et al., 2010) (Fig. 1). Consistent with the loss of
neurogenic competence of NSCs during development, Neurog1 gains
H3K27me3 in the promoter, and its expression becomes repressed as
NSC differentiation leans toward astrocyte production. Ezh2 directly
targets Neurog1 and suppresses its expression by catalyzing
H3K27me3 in the promoter region (Hirabayashi et al., 2009). This
eventually limits the responsiveness of NSCs to Wnt signaling and
contributes to switching the competence of NSCs from neurogenic to
gliogenic. In fact, NSC-speciﬁc conditional deletion of Ezh2 before the
onset of astrocyte differentiation prolongs neuronal production and
delays the production of astrocytes (Pereira et al., 2010).
Polycomb repressive complexes also affect layer formation of the
cortex. Newly generated neuronsmigrate to the outside of the cortical
plate along with radial processes of NSCs, which extend to the pial
surface, and establish the cortical layer in an inside-out order: deep
layer (DL) neurons are generated ﬁrst, followed by upper layer (UL)
neurons (Greig et al., 2013; Molyneaux et al., 2007). The Fez
transcription factor family member zinc-ﬁnger 2 (Fezf2) plays a key
role in the differentiation of NSCs into DL neurons, and its expression
governs the period for the production of DL neurons (Chen et al.,
2005a, 2005b; Molyneaux et al., 2005). Ring1B, one of the compo-
nents of PRC1, represses the expression of Fezf2 and contributes to the
termination of DL neuron production. Deletion of Ring1B in NSCs
prolongs the expression of Fezf2, resulting in increased production of
DL neurons (Morimoto-Suzki et al., 2014).
Histone acetylation also affects appropriate layer formation by
regulating the fate propensity of NSCs from DL neurons to UL neuron
production. Acetylation of histone N-terminal tails induces relaxation
of the nucleosomes by decreasing the interaction of the positively
charged histone tails with the negatively charged DNA. Histone
deacetylases (HDACs) condense chromatin by removing acetyl groups
from histone tails, which prevents the access of transcription factors
to their cognate sites and leads to transcriptional repression. Blocking
HDAC activity in the neurogenic phase, using the HDAC inhibitor
suberoylanilide hydroxamic acid, decreases the production of DL
neurons and increased UL neurons from NSCs (Yuniarti et al., 2013).
This ﬁnding suggests that histone acetylation participates in the
transition from DL neuron to UL neuron production during cortical
development.
As in neuronal differentiation, bHLH transcriptional factors play a
critical role in oligodendrocyte differentiation. Shh signaling is highly
activated in the ganglionic eminence of the ventral telencephalon,
where oligodendrocytes are induced by the Shh-induced bHLH
transcriptional factors Olig1 and Olig2 (Lu et al., 2000; Tekki-Kessaris
et al., 2001). These 2 factors play essential roles in oligodendrocyte
differentiation and maturation. Compound Olig1 and Olig2 knock-out
(KO) mice displayed complete loss of oligodendrocytes (Zhou and
Anderson, 2002). Olig2 is essential for the initiation of oligodendro-
cyte differentiation, whereas Olig1 is required for the maturation of
oligodendrocytes and the remyelination of axons after oligodendro-
cyte ablation (Arnett et al., 2004; Dai et al., 2015; Liu et al., 2007; Xin
et al., 2005). bHLH transcription factors activate expression of
downstream targets by forming dimers with ubiquitously expressed
bHLH E-proteins such as E12 and E47. However, the negative HLH
factors hairy and enhancer of split (Hes) and inhibitor of differenti-
ation (Id) inhibit bHLH transcription factors by competing with them
for dimerization with E-proteins. Wnt signal activation induces
expression of the negative HLH factors Id2 and 4, limiting the
generation of oligodendrocytes (Ye et al., 2009). The activation ofWnt
signaling declines at the onset of oligodendrocyte differentiation,
implying that Wnt signaling inﬂuences the timing of oligodendrocyte
differentiation during brain development (Langseth et al., 2010).
HDACs modulate the inhibition of oligodendrocyte production by
Wnt signaling and ensure oligodendrocyte development. HDAC
activity is essential for the development and maturation of oligoden-drocytes: treatment with HDAC inhibitor attenuates oligodendrocyte
differentiation (Marin-Husstege et al., 2002), and HDAC1 and HDAC2
double KO mice show severe defects in oligodendrocyte production
and maturation (Ye et al., 2009) (Fig. 1). Wnt signaling stabilizes
β-catenin, which then induces downstream targets of Wnt signaling,
such as Id2 and 4, by forming a complex with transcription factor 7–
like 2 (TCF7L2), a downstream effector. HDAC1 and 2 bind
competitively to TCF7L2with β-catenin, thereby inhibiting expression
of the Id2 and 4 genes (Ye et al., 2009). Another HDAC partner that
promotes differentiation of oligodendrocytes, Yin Yang 1 (YY1), has
been identiﬁed through a binding motif analysis in the promoters of
up-regulated genes involving treatment with HDAC inhibitor. The Id4
and TCF7L2 promoters contain a YY1 binding site, and YY1 inhibits
expression of these genes by recruiting HDAC1 and 2 to their
promoters (He et al., 2007) (Fig. 1).
1.3. Role of DNA methylation in regulating gliogenic competence of NSCs
After the production of neurons, NSCs start to give rise to astrocytes.
The later onset of astrogliogenesis results from a dramatic change of
DNA methylation in astrocyte-speciﬁc promoters. DNA methylation
predominantlyoccurs at the cytosine residueof CpGdinucleotides in the
mammalian genome. DNA methylation in gene promoters has been
associated with gene repression and stem cell differentiation in various
tissues, including the CNS. Glial ﬁbrillary acidic protein (Gfap) and S100β
are representative genes that are expressed speciﬁcally in astrocytes.
Their promoters are highly methylated in NSCs from early to
midgestational stages, limiting the responsiveness of NSCs to astrocyte
differentiation–inducing factors. Members of the interleukin 6 family of
cytokines, such as leukemia inhibitory factor and ciliary neurotrophic
factor, have been identiﬁed as astrocyte-inducing factors. These factors
induce astrocyte differentiation of NSCs by activating the Janus kinase
(JAK) signal transducer and activator of transcription 3 (STAT3)
pathway. Astrocyte-speciﬁc genes, including Gfap and S100β, have
STAT-binding sites in their promoters, and their expression is induced
by activation of the JAK-STAT pathway during the gliogenic phase.
However, NSCs in the neurogenic phase fail to express these genes even
if the JAK-STATpathway is activated. This is because STAT3-binding sites
are methylated in NSCs, which interferes with the binding of STAT3 to
the promoter region, resulting in the inhibition of astrocyte-speciﬁc
gene expression during the neurogenic phase (Bonni et al., 1997; He et
al., 2005; Nakashima et al., 1999a,b; Namihira and Nakashima, 2013;
Rajan and McKay, 1998). Methylated DNA in astrocyte-speciﬁc genes
undergoes demethylation during development, enabling NSCs to
respond to astrocyte-inducing factors. Thus, demethylation of astro-
cyte-speciﬁc gene promoters explains, at least partially, how NSCs
switch their competence fromneurogenic to gliogenic. In support of this
model, deletion of the gene encoding DNA methyltransferase 1
(Dnmt1), an enzyme responsible for the maintenance of DNA
methylation after DNA replication, causes precocious astrocyte differ-
entiation of NSCs in the neurogenic phase (Fan et al., 2005) (Fig. 1).
These ﬁndings raise further question of howDNA demethylation of
astrocyte-speciﬁc genes occurs. Demethylation of DNA occurs via 2
distinct processes. One of these is passive demethylation, which
progresses in a DNA replication–dependent manner as Dnmt1 is
excluded from the methylation target site. Because neurons are the
ﬁrst cell type produced by NSCs during development—meaning that
neurons are the ﬁrst cell type with which NSCs make contact, other
than NSCs themselves—we hypothesized that some signal from
neurons triggers DNA demethylation and confers the competence to
produce astrocytes on remaining NSCs. Newly generated immature
neurons express the ligands of Notch, Delta-like 1 and JAGGED1, and
they activate Notch signaling, which induces expression of nuclear
factor IA (NFIA) in remaining NSCs (Namihira et al., 2009; Namihira
and Nakashima, 2013). NFIA then binds to the astrocyte-speciﬁc gene
promoters, which leads to the dissociation of Dnmt1 from the
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tion. This partially accounts for how DNA demethylation of astro-
cyte-speciﬁc gene promoters is induced during development and also
why astrocyte production begins following the neurogenic phase.
However, the precise molecular mechanism of how binding of NFIA
leads to the dissociation of Dnmt1 from astrocyte-speciﬁc gene
promoters remains elusive. It has been shown that, during DNA
replication, Dnmt1 is recruited to methylation target sites by Uhrf1
(ubiquitin-like containing PHD and RING ﬁnger domains 1; also
known as Np95), which is highly expressed by NSCs in the developing
brain (Bostick et al., 2007; Murao et al., 2015; Sharif et al., 2007).
Therefore, Uhrf1 may be involved in the mechanism by which NFIA
induces exclusion of Dnmt1 from the target site. In any case, a more
detailed mechanism to explain DNA demethylation in astrocyte-spe-
ciﬁc genes must await further investigation.
Anothermechanism for DNAdemethylation is active demethylation,
which occurs in a replication-independentmanner, and this ismediated
by Ten-eleven translocation (TET) family proteins. TETs convert
5′-methylcytosine (5mC) to 5′-hydroxymethylcytosine (5hmC) in a Fe
(II)– and α-ketoglutarate–dependent fashion (Pastor et al., 2013; Wu
and Zhang, 2010). 5hmC is thought to serve as an intermediate in the
active DNA demethylation process (Kohli and Zhang, 2013). TET
proteins further oxidize 5hmC to 5-formylcytosine (5fC) and 5-carbox-
ylcytosine (5caC). These oxidized cytosines can then be successively
excised by thymine-DNA glycosylase (TDG) followed by replacement
with unmodiﬁed 5mC via the base excision repair pathway (He et al.,
2011; Ito et al., 2011; Kohli and Zhang, 2013; Zhang et al., 2012).
During embryonic brain development, high levels of 5hmC are
detected in the cortical plate, and the levels increase with neuronal
differentiation (Hahn et al., 2013). This enrichment of 5hmC inversely
correlates with H3K27me3. 5hmC is observed in the gene body of
neuronal function–related genes, such as sex-determining region Y
(SRY)-related HMG box 5 (Sox5), B-cell chronic lymphocytic leukemia/
lymphoma 11B (Bcl11b), andmyelin transcription factor 1-like (Myt1l).
Concomitant with their expression, these genes lose H3K27me3 from
their promoter and gain 5hmC marks in the gene body during the
progression of neuronal differentiation. This unique mode of
occupancy of 5hmC and H3K27me3 is indicative of its mechanistic
role in neuronal differentiation of NSCs. In fact, knockdown (KD) of
Ezh2 promotes the neuronal differentiation of NSCs, and overexpres-
sion of Tet1 and Tet2 further enhances the Ezh2 KD-promoted
neuronal differentiation. This suggests that formation of 5hmC and
loss of H3K27me3 cooperate to promote neuronal differentiation
during the neurogenic phase (Hahn et al., 2013). Interestingly,
enrichment of 5hmC during this time does not lead to substantial
DNA demethylation, suggesting that 5hmC functions as a stable
epigenetic mark and takes part in regulating gene expression.
Similar to the enrichment of 5hmC, 5caC also displays transient
accumulation in the genome speciﬁcally during differentiation of NSCs
(Wheldon et al., 2014), and the accumulation of 5caC becomes more
obvious as NSCs are stimulated to differentiate into glial cells. Indeed,
TDG KD increased 5caC and 5fC levels during glial differentiation. In
particular, glial gene promoters such as Gfap, Olig1, and Olig2 acquire
5caC and 5fC during glial differentiation. Given that TDG excises both
5caC and 5fC and leads to DNA demethylation, this enrichment of 5caC
in the promoters of astrocyte-speciﬁc genes such as Gfap suggests the
possibility that DNA demethylation of astrocyte-speciﬁc genes also
occurs through active DNA demethylation. Whatever the mechanism,
these ﬁndings support the idea that DNA demethylation warrants the
timing of gliogenesis in the developing brain.
1.4. Role of noncoding RNAs in embryonic NSC differentiation
Noncoding RNAs are transcribed from DNA but not translated into
proteins. Among these, microRNAs (miRNAs) and long noncoding
RNA (lncRNA) play a variety of roles in ﬁne-tuning gene expression bytranscriptional and posttranscriptional regulation. miRNAs are known
to contribute to posttranscriptional repression of gene expression and
have been explored extensively in recent years. These studies have
shown that, in addition to histone modiﬁcation and DNAmethylation,
noncoding RNAs also participate in the mechanisms that ensure the
sequential production of distinct neural cell types from NSCs during
development.
Chicken ovalbumin upstream promoter-transcription factor I and
II (COUP-TFI/II) induces competence transition of NSCs from neuro-
genic to gliogenic during development. The expression of COUP-TFI/II
is high in the gliogenic phase, and this facilitates the DNA
demethylation of the Gfap promoter (Naka et al., 2008). A recent
study has identiﬁed miR-17/106, whose expression in NSCs increases
in the neurogenic phase and gradually decreases along with the
transition to the gliogenic phase, as a downstream effector of
COUP-TFI/II (Naka-Kaneda et al., 2014). miR-17/106 targets p38
(also known as MAPK14) to regulate the transition of NSC
competence and plays an essential role in determining the
responsiveness of NSCs to gliogenic signals (Fig. 1). Overexpression
of p38 or suppression of miR-17/106 in embryonic stem cell–derived
neurogenic NSCs induces precocious astrocytic differentiation in the
presence of astrocyte differentiation-inducing factors. Therefore, the
COUP-TFI/II–miR-17/106–p38 axis is a critical regulator for the
neurogenic-to-gliogenic NSC competence transition.
Moreover, miR-153 also regulates the acquisition of gliogenic
potential of NSCs (Tsuyama et al., 2015) (Fig. 1). miR-153 targets
messenger RNAs (mRNAs) for NFIA and B, 2 essential regulators for
the initiation of gliogenesis that act by inducing demethylation of
astrocytic gene promoters. Gain- and loss-of-function experiments
using miR-153 in vitro and in vivo suggest that miR-153–mediated
ﬁne tuning of NFIA and B expression is essential for the acquisition of
gliogenic potential by NSCs during CNS development.
In addition to these miRNAs, a very recent study has revealed that
miR-9, which shows speciﬁc enrichment in the brain, is also involved
in fate speciﬁcation of NSCs (Zhao et al., 2015) (Fig. 1). miR-9 is
induced by Neurog1, and it directly targets mRNA of Lif receptor beta
(Lifr-beta), Il-6 signal transducer (Il6st), and Jak1, which are major
components of the JAK-STAT pathway, resulting in the inhibition of
astrogliogenesis during the neurogenic stage. miR-9 KD in neurogenic
NSCs increased astrocyte differentiation both in vitro and in vivo,
whereas its overexpression decreased it. Therefore, as well as miR-17/
106 and miR-153, miR-9 is also an important regulator for the fate
speciﬁcation of NSCs.
Furthermore, many other miRNAs have been identiﬁed as being
speciﬁcally expressed in the mammalian brain. For example, Let-7 and
miR-137 are highly expressed from the embryonic to the adult brain. In
addition, each neural cell type differentially expresses distinct miRNAs:
miR-124 is highly expressed in neurons, whereas miR-23, 26, 29, and
146a are predominantly expressed in astrocytes (Iyer et al., 2012;
Smirnova et al., 2005). These cell type–speciﬁc expression patterns of
miRNAs suggest their critical roles in regulating some function in each
cell type, such as NSC proliferation and differentiation.
Among these miRNAs, miR-124 comprises 25%–48% of total
miRNAs in the brain and has been extensively studied (Lagos-Quin-
tana et al., 2002). miR-124, whose expression increases during brain
development, promotes neuronal differentiation of NSCs (Fig. 1).
miR-124 directly targets the small C-terminal domain phosphatase 1
(SCP1), an antineural factor expressed in nonneuronal tissues. SCP1 is
recruited to repressor element 1–containing neural genes by
repressor element 1 silencing transcription factor (REST), also
known as neuron-restrictive silencer factor, and is involved in their
repression (Visvanathan et al., 2007; Yeo et al., 2005). miR-124
suppresses SCP1 expression during CNS development, thereby
inducing neurogenesis. In addition, miR-124 down-regulates the
expression of the RNA-binding protein polypyrimidine tract binding
protein 1, a global repressor of CNS-speciﬁc alternative pre-mRNA
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plays an important role in the differentiation of NSCs to mature
neurons by increasing neuron-speciﬁc transcript levels.
Another brain-enriched miRNA, miR-137, plays an important role
in regulating fate determination of NSCs (Sun et al., 2011b) (Fig. 1).
Overexpression of miR-137 suppresses proliferation and accelerates
neuronal differentiation of NSCs. In this regard, it has been suggested
that miR-137 makes a negative feedback loop with the histone H3K4
demethylase lysine-speciﬁc demethylase 1 (LSD1) and the orphan
nuclear receptor TLX, which is an essential regulator of NSC
self-renewal. miR-137 targets LSD1 and inhibits its function. On the
other hand, TLX represses the expression of miR-137 by recruiting
LSD1 to the genomic region of miR-137. This feedback loop of
miR-137 with LSD1 and TLX may regulate the balance between
proliferation and differentiation of embryonic NSCs during neural
development.
1.5. Epigenetic regulation in adult neurogenesis
Even after brain development is completed, a limited number of
NSCs is maintained in the adult brain. These NSCs contribute to brain
functions through daily production of neurons. Adult neurogenesis
occurs in 2 restricted brain regions (Bond et al., 2015; Christian et al.,
2014; Lledo et al., 2006; Ma et al., 2009a; Ming and Song, 2011). The
subventricular zone (SVZ) of the lateral ventricle is one of the
restricted regions in which neurogenesis persists. NSCs in the SVZ,
named type B cells, proliferate infrequently and mostly display a
quiescent state in the cell cycle. In the process of neurogenesis, they
ﬁrst give rise to transit-amplifying NPCs (type C cells), which then
proliferate and differentiate into neuroblasts (type A cells). Neuro-
blasts migrate into the olfactory bulb (OB) along the rostral migratory
stream and differentiate into mature granule and periglomerular
neurons there (Fig. 2).
The subgranular zone (SGZ) of the adult hippocampal dentate
gyrus (DG) also sustains NSCs into adulthood. Similar to the adult SVZ,
relatively quiescent radial glia–like cells (type 1 cells) serve as NSCs in
the SGZ. Type 1 cells give rise to transit-amplifying NPCs (type 2a/b
cells), and they eventually differentiate into neurons through the
neuroblast stage (type 3 cells) (Fig. 3). Newly generated neurons
migrate into the granule cell layer along blood vessels and integrate in
preexisting neural circuits (Sun et al., 2015). These newly generated
neurons have been implicated in various hippocampal functions, such
as hippocampus-dependent learning and memory.
For adult neurogenesis to occur, NSCs must go through several steps
including maintenance and proliferation of Neural Stem/Precursor Cell
(NS/PC) and neuronal commitment, migration, and maturation
(Christian et al., 2014; Duan et al., 2008; Sun et al., 2011a) (Figs. 2, 3).
A growing number of studies have shown that these processes in adult
neurogenesis are governed by both cell extrinsic and intrinsic factors
including extracellular signals from the stem cell niche, transcription
factors, and epigenetic regulators (Bond et al., 2015; Fuentealba et al.,
2012; Jobe et al., 2012; Ming and Song, 2011; Sun et al., 2011a).
Moreover, to ensure neurogenesis in the adult brain, NSCs need to be
maintained from embryonic to adult stages. Thus, the mechanism that
sustains NSCs into adulthood is also pivotal for adult neurogenesis to
occur. For instance, recent studies have elucidated the importance of
histone modiﬁcations in regulating these processes to warrant neuro-
genesis in the adult brain (Lim et al., 2009; Molofsky et al., 2003). In this
section, we introduce examples of epigenetic mechanisms contributing
to the maintenance of adult neurogenesis.
1.6. Histone modiﬁcations in adult NS/PCs
The PcG and Trithorax (TrxG) complexes have been implicated in
regulating adult neurogenesis. The PcG complex is responsible for
gene repression, which is mediated by H3K27 methylation, whereasthe TrxG complex catalyzes trimethylation of H3K4 (H3K4me3) in
promoter-proximal nucleosomes to activate expression of their target
genes (Blackledge et al., 2015; Ng and Gurdon, 2008; Ringrose and
Paro, 2007). PRC1 consists of multiple subunits, and one of its
components, B cell–speciﬁc Moloney murine leukemia virus integra-
tion site 1 (Bmi1), contributes to modulating the proliferation
capacity of NSCs and maintaining them to adulthood (Fig. 2). Deletion
of Bmi1 attenuates the proliferation capacity of NSCs, resulting in the
depletion of NSCs during development (Molofsky et al., 2003). This
occurs through up-regulation of the cell cycle–dependent kinase
inhibitor p16Ink4a, whose deletion partially rescues the phenotype of
Bmi1 KO mice.
The TrxG complex component mixed-lineage leukemia 1 (Mll1)
histone methyltransferase is required for neuronal differentiation in
the SVZ (Lim et al., 2009) (Fig. 2). Deletion of Mll1 in NSCs caused no
defects in NSC proliferation, survival, and glial differentiation but
severely impaired neuronal differentiation. Mll1 is responsible for
H3K4me3, and its recruitment to gene promoters has been associated
with gene activation. Mll1 directly targets distal-less homeobox 2
(Dlx2), a homeodomain-containing transcription factor important for
neurogenesis in the OB. When Dlx2 expression is active, its promoter
shows high level of H3K4me3. However, in the absence of Mll1, the
Dlx2 promoter enters the bivalent state, i .e. , a posed
state for transcription harboring both repressive (H3K27me3) and
active (H3K4me3) histone modiﬁcations. These ﬁndings indicate that
Mll1-mediated resolutionof thepoised state (H3K4me3 + H3K27me3)
to the active state (H3K4me3 only) of the Dlx2 promoter is crucial for
neuronal differentiation of NSCs.
One model to explain how bivalency is resolved by Mll1 is the
cooperation of Mll1 with histone demethylase against H3K27me3 to
activate target gene expression. A Jumonji domain containing 3
(Jmjd3; also called KDM6B), which is an H3K27me3-speciﬁc
demethylase belonging to the family of JmjC domain–containing
proteins, also acts as a critical activator of neuronal differentiation of
adult SVZ NSCs (Fig. 2). Jmjd3 activates expression of a number of
neuronal genes, including doublecortin, Nkx2.2, Dlx2, and Dlx5 (Jepsen
et al., 2007; Park et al., 2014). Upon neuronal differentiation, Jmjd3 is
enriched in both the promoter and enhancer of Dlx2. This is coupled
with decreased H3K27me3 level and increased Dlx2 expression.
Interestingly, this enrichment of Jmjd3 is impaired by deletion ofMll1,
suggesting that Mll1 is required for the recruitment of Jmjd3 to the
gene expression regulatory region. These ﬁndings highlight the
importance of crosstalk between histone methylation enzymes in
adult neurogenesis.
Adult neurogenesis is known to be regulated by many physiolog-
ical and pathologic conditions. One of the pathologic conditions,
kainic acid–induced seizure, leads to aberrant neurogenesis in the
adult hippocampus (Jessberger et al., 2005, 2007a, 2007b; Matsuda et
al., 2015). The HDAC inhibitor valproic acid, an antiepileptic agent that
is widely used in human clinical treatment, suppresses kainic acid–
induced aberrant proliferation of NS/PCs in the adult DG, contributing
to the alleviation of cognitive impairment in hippocampus-dependent
learning (Jessberger et al., 2007a,b). In addition, valproic acid also
functions to induce neuronal differentiation of adult hippocampal
NSCs by up-regulating the proneural gene NeuroD, whereas it inhibits
astrocyte and oligodendrocyte differentiation (Hsieh et al., 2004). In
the HDAC family, HDAC2 plays a critical role in neuronalmaturation in
both adult hippocampal DG and SVZ (Figs. 2, 3). It has been shown
that speciﬁc ablation of HDAC2 in NSCs impairs neuronal differenti-
ation and induces abnormal maturation of newborn neurons and cell
death in both SGZ and SVZ, although the proliferation rate of
transit-amplifying NPCs is increased by HDAC2 deletion. This
combination of increased proliferation and defective neuron gener-
ation in HDAC2-deﬁcient mice may result from the prolonged
expression of stem cell–speciﬁc genes during neuronal differentiation.
Sox2, an important transcription factor for proliferation and stemness
Fig. 2. Schematic representation of adult neurogenesis and factors relevant to epigenetic regulation in the SVZ and OB. Adult neurogenesis in the SVZ is composed of 5 stages: (1)
stem cell maintenance and proliferation, (2) fate speciﬁcation, (3) migration, (4) survival, and (5) neuronal maturation and integration. Brieﬂy, radial glia-like cells (type B) become
activated and produce transit-amplifying NPCs (type C), which frequently proliferate and generate neuroblasts (type A). Newly generated neuroblasts migrate along the rostral
migratory stream and differentiate into immature neurons in the OB. Finally, synaptic integration and maturation of granule cells and periglomerular neurons are induced in the OB.
Representative epigenetic factors that are relevant in regulating each stage of adult SVZ neurogenesis are also shown. Abbreviations: LV, lateral ventricle; OB, olfactory bulb; RMS,
rostral migratory stream. →, promotion; ⊣, inhibition.
6 N. Murao et al. / Neuroepigenetics 5 (2016) 1–10of NSCs, is not normally expressed in neuroblasts, which are already
committed to differentiate into neurons. However, Sox2 expression is
sustained even in the neuroblasts in the DGs of HDAC2-deﬁcient mice,
suggesting that HDAC2 is essential to terminate Sox2 expression as
NS/PCs differentiate into neurons and that Sox2 expression should beFig. 3. Schematic diagram of the current view of lineage relationships and epigenetic regula
proceeds through 4 stages: (1) stem cell maintenance and proliferation, (2) fate speciﬁcation
numbers on the ﬁgure indicate the detailed developmental steps of adult hippocampal n
proliferation of precursor and intermediate progenitors (type 2a, 2b, transit-amplifying cells
[5] maturation of immature neurons. Epigenetic factors, including DNAmethylation, histone
of crosstalk between each pathway. Solid (frequent) and dashed (slow or rare) semicircular a
cell layer; SGZ, subgranular zone. →, promotion; ⊣, inhibition.repressed in neuroblasts and neurons to ensure proper neuronal
differentiation and maturation (Jawerka et al., 2010).
Sox2 limits the activity of the PRC2 complex to suppress excessive
acquisition of H3K27me3 at the regulatory regions of proneural and
neurogenic genes, such as Neurog2, NeuroD1, and brain-derivedtion during adult hippocampal neurogenesis. Adult hippocampal neurogenesis mainly
, (3) survival, and (4) neuronal maturation and integration into preexisting circuits. The
eurogenesis: [1] activation of quiescent radial glia-like cells (type 1) in the SGZ, [2]
), [3] generation of neuroblasts (type 3), [4] differentiation into immature neurons, and
modiﬁcation, and noncoding RNAs, regulate adult hippocampal neurogenesis by means
rrows indicate the cell division frequency of each cell type. Abbreviations: GCL, granule
7N. Murao et al. / Neuroepigenetics 5 (2016) 1–10neurotrophic factor (Bdnf) (Amador-Arjona et al., 2015). These genes
have bivalency in their promoters, whereby their expression is poised
to be activated once NSCs initiate neuronal differentiation in response
to the stimuli of neurogenic cues. Sox2 interacts with these gene
promoters and precludes the recruitment of the PRC2 component
Ezh2. In the absence of Sox2, H3K27me3, but not H3K4me3, increases
in the poised proneural and neurogenic gene promoters, correlating
with the increased accumulation of Ezh2. Moreover, Wnt signaling, a
neurogenic cue that induces neurogenesis in adult as well as
embryonic stages, activates the expression of poised proneural and
neurogenic genes. Sox2-deﬁcient NSCs, however, fail to express these
genes upon Wnt stimulation. Speciﬁc ablation of Sox2 in adult
hippocampal NSCs impairs both proneural and neurogenic gene
expression, resulting in decreased neurogenesis, accompanied by
increased cell death and functionally aberrant newborn neurons.
These ﬁndings suggest the important role of Sox2 in maintaining
permissive epigenetic states of neurogenesis-related genes in the
adult hippocampal NSCs, allowing these genes to respond to
neurogenic cues immediately.
1.7. DNA methylation in adult neurogenesis
The role of DNA methylation in adult neurogenesis is still unclear
compared with other epigenetic regulation characters such as histone
modiﬁcation or noncoding RNAs. Expression of Dnmt1 and of the de
novo DNA methyltranseferase Dnmt3a, but not 3b, is observed in the
adult brain. Dnmt1 is particularly highly expressed in proliferative NS/
PCs compared with quiescent NSCs and postmitotic neurons and
astrocytes in the adult hippocampus. Although deletion of Dnmt1 in
adult NSCs does not affect their proliferation or differentiation, it
decreases the survival of newly generated neurons in the adult
hippocampal DG (Noguchi et al., 2015). Interestingly, Dnmt1 KO in
postmitotic neurons does not affect their survival, suggesting that
DNA methylation maintained by Dnmt1 in the NSC stage plays an
important role for the survival of newly generated neurons only after
NSCs differentiate into neurons in the adult hippocampus (Fig. 3). On
the contrary, Dnmt3a is reportedly associated with adult neurogen-
esis (Wu et al., 2010) (Fig. 2). Deletion of Dnmt3a decreased neuronal
differentiation of NSCs in the SVZ, resulting in a reduction of
neuroblasts migrating into the OB. Dnmt3a targets nonpromoter
regions of neurogenic genes and induces their expression. DNA
methylation and Dnmt3a occupancy in nonpromoter regions are
negatively correlated with elevation of H3K27me3 and enrichment of
the PRC2 components Ezh2 and suppressor of zeste 12. This suggests
that Dnmt3a-dependent methylation promotes neuronal differentia-
tion by inhibiting PRC2-mediated repression of gene expression.
In addition to DNAmethyltransferase, Tet1, an important factor for
active demethylation via oxidation of 5mC, also plays an important
role in regulating adult hippocampal neurogenesis (Zhang et al.,
2013) (Fig. 3). Tet1 deﬁciency impairs the proliferation of adult NSCs
and causes DNA hypermethylation of genes involved in proliferation
and neuronal protection, including Galanin, Ng2, and Neirglobin (Ngb),
resulting in decreased neurogenesis. Moreover, Tet1 KO mice display
impaired spatial learning andmemory, suggesting that Tet1-mediated
DNA demethylation is important for cognition.
Active DNA demethylation occurs not only in NS/PCs but also in
the cells providing the niche for NS/PCs, which contributes to
regulating the expression of neurogenic cues. A member of the
growth arrest and DNA damage 45 (Gadd45) gene family, Gadd45b, is
induced in mature hippocampal neurons by neuronal activity, such as
electroconvulsive treatment and voluntary running. Gadd45b expres-
sion in mature hippocampal neurons is dependent on depolarizatio-
n-induced calcium inﬂux and calmodulin kinase activity (Greer and
Greenberg, 2008; Ma et al., 2009b). Gadd45b has been implicated in
the DNA excision repair–based DNA demethylation mechanism and
induces active DNA demethylation in vertebrates. In the adult mousehippocampus, Gadd45b promotes activity-induced DNA demethyla-
tion within the regulatory region IX of Bdnf and brain-speciﬁc
promoter B of ﬁbroblast growth factor 1 (Fgf1). These 2 genes play
crucial roles in adult neurogenesis as well as neuronal survival and
maturation. Thus, Gadd45-dependent DNA demethylation and ex-
pression of secreted factors, such as BDNF and FGF1, inﬂuence the
neurogenic niche, and these proteins serve as key regulators of
homeostasis in adult neurogenesis (Fig. 3).
DNA methylation normally leads to repression of gene expression
through the recruitment of methylated DNA-binding protein family
members such as methyl-CpG-binding protein 1 (MBD1) and
methyl-CpG-binding protein 2 (MeCP2). These 2 factors are also
involved in controlling the expression of neurogenic cues. NSC-spe-
ciﬁc MBD1 KO decreases adult neurogenesis and impairs spatial
learning. MBD1 directly interacts with the promoter region of Fgf2, an
essential growth factor for NSCs. In the absence of MBD1, the Fgf2
promoter region becomes hypomethylated, resulting in increased
expression of Fgf2 in NSCs and further leading to neuronal
differentiation arrest (Li et al., 2008a) (Fig. 3). MeCP2, the causal
gene of Rett syndrome, is highly expressed in postmitotic neurons and
functions as amajor regulator for neuronal gene expression in the CNS
(Amir et al., 1999; Lyst and Bird, 2015; Shahbazian et al., 2002).MeCP2
KO mice display no deﬁciencies in early postnatal neurogenesis, but
neuronal maturation of newly generated neurons is impaired in the
adult hippocampal DG (Smrt et al., 2007) (Fig. 3). One of the
best-known targets of MeCP2 is Bdnf, which regulates several aspects
of neurogenesis, including proliferation, differentiation of NSCs, and
development and survival of newborn neurons (Li et al., 2008b;
Murray and Holmes, 2011). MeCP2 physically occupies the hyper-
methylated Bdnf promoter and suppresses its expression. This
interaction between MeCP2 and the Bdnf promoter is disrupted by
the induction of DNA demethylation in response to neuronal activity,
which increases Bdnf transcription. In addition, neuronal activity–
induced calcium inﬂux causes posttranscriptional modiﬁcation of
MeCP2, such as phosphorylation at Ser421, which decreases the
afﬁnity of MeCP2 for the Bdnf promoter and facilitates its transcription
(Chen et al., 2003; Zhou et al., 2006b). MeCP2 Ser421 phosphorylation
is induced in response to neuronal stimulation and plays a signiﬁcant
role in synapse development and behavior (Cohen et al., 2011).
1.8. Noncoding RNAs in adult neurogenesis
The roles of miRNA in NSCs and in adult neurogenesis have been
extensively studied as well. Accumulating evidence indicates that
miRNA plays a substantial role in ﬁne tuning the progression of adult
neurogenesis (Figs. 2, 3).
In the SVZ of the adult mammalian brain, brain-speciﬁc miR-124 is
highly expressed during the transition from transit-amplifying NPCs
to neuroblasts and immature neurons (Cheng et al., 2009). miR-124
promotes the differentiation of the NPCs into neuroblasts and controls
the timing of lineage progression. miR-124 has several known direct
targets in the SVZ including Jag1, Dlx2, and Sox9. Because these genes
are known to contribute to distinct steps in adult neurogenesis, such
as self-renewal and neuronal differentiation of NSCs, it is conceivable
that miR-124 affects multiple aspects of adult neurogenesis in the SVZ
(Cheng et al., 2009; Doetsch et al., 2002; Nyfeler et al., 2005) (Fig. 2).
Another representative miRNA that plays an important role in NSC
proliferation and differentiation is miR-137, which is a direct target of
Sox2 and MeCP2 in adult SGZ (Szulwach et al., 2010). Overexpression
of miR-137 promotes proliferation of NSCs in the hippocampal DG,
whereas its repression enhances the differentiation of NSCs into both
neurons and astrocytes. One of the targets of miR-137 is Lsd1, which is
known to suppress the proliferation of NSCs in the embryonic brain
and adult hippocampus (Sun et al., 2010) (Fig. 3). In addition,
miR-137 also regulates neuronal maturation, dendritic elaboration,
and spine development by suppressing mind bomb 1 expression
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important for neurodevelopment, and its overexpression partially
rescues the neuronal maturation impairments caused by miR-137
overexpression. MBD1 targets miR-184 and represses its expression
in adult NSCs (Liu et al., 2010). miR-184 targets mRNA for Numb-like
(Numbl), an inhibitor of Notch signaling, for maintenance of adult
NSCs. High levels of miR-184 expression promote proliferation at the
expense of differentiation of adult hippocampal NSCs. Thus, MBD1,
miR-184 and Numbl form a regulatory network to maintain the
balance between proliferation and differentiation of NSCs in the adult
hippocampal DG (Fig. 3).
Recently, the roles of lncRNA in adult neurogenesis have just
begun to be studied. The lncRNAs Dlx1as and Six3os are expressed in
NSCs in the SVZ and play key roles in the glial-neuronal lineage
speciﬁcation of adult NSCs (Ramos et al., 2013) (Fig. 2). Dlx1as is
transcribed from the Dlx1/2 gene cluster, whereas Six3os is tran-
scribed from a site proximal to the Six3 homeobox gene (Dinger et al.,
2008; Liu et al., 1997). Loss-of-function analysis in the SVZ revealed
that both Dlx1as and Six3os affect fate determination of adult NSCs
into neurons, but Six3os has an additional function in regulating NSC
differentiation into oligodendrocytes. Another example of functional
lncRNA is the rhabdomyosarcoma 2-associated transcript (RMST),
which is speciﬁcally expressed in the brain and whose expression is
repressed by REST/neuron-restrictive silencer factor. RMST directly
interacts with Sox2 and tethers it to the promoter regions of
neurogenic transcription factors such as Ascl1, Dlx1, and Neurog2 to
induce their expression and the neuronal differentiation of NSCs (Ng
et al., 2012, 2013). Pinky (Pnky) has been identiﬁed by means of
RNA-seq as a neural-speciﬁc lncRNA, expressed in both embryonic
and adult NSCs (Ramos et al., 2015). Pnky interacts with the splicing
regulator polypyrimidine tract binding protein 1 and suppresses
neuronal differentiation of NSCs by inhibiting the precise expression
and alternative splicing of key genes related to neuronal differenti-
ation (Fig. 2).
2. Closing remarks and perspective
In the last 2 decades, the existence of NSCs even in human brain
has been clearly proven, and NSC research is currently progressing
with dramatic speed and nurturing the hope that NSCs can be used for
the clinical treatment of various neural disorders and diseases. For
example, transplantation of NSCs into the lesion site of injured spinal
cord has been shown to have great potential to recover locomotion
ability in patients affected with spinal cord injury (Abematsu et al.,
2010; Fujimoto et al., 2012; Iwanami et al., 2005; Ogawa et al., 2002).
In addition, implanting cells that are genetically engineered to
become dopaminergic neurons, one of the neuronal subtypes
speciﬁcally lost in Parkinson's disease, into the brain of Parkinson's
disease model animals has been undertaken to ask if such a strategy
could be a clinical treatment for Parkinson's disease (Kim et al., 2011;
Liu et al., 2012). For these and other neuronal disorders, establishing a
treatment to recover abilities of the CNS that are lost in diseases and
injury is now becoming one of the most encouraging and worthwhile
challenges in NSC research. In terms of producing desirable cells from
NSCs for such treatments, a deep understanding of the mechanisms
regulating NSC proliferation and differentiation is essential. Develop-
ment of an in vitro culture system for NSCs triggered research to verify
the signaling molecules that enable them to proliferate and
differentiate into speciﬁc cell types in the CNS. These approaches
have already identiﬁed many neurogenic and gliogenic molecules, but
they have also uncovered the existence of intrinsic mechanisms in
NSCs that inﬂuence their responsiveness to these cues. As we have
discussed in this review, epigenetic regulation constitutes these
intrinsic mechanisms, and recent researches have shown its signiﬁ-
cant contribution to brain development and adult neurogenesis.
Nevertheless, there are still many questions to be addressed regardingthe mechanisms by which epigenetic modiﬁcations regulate the
maintenance and differentiation of NSCs. The current revolution of
next-generation sequencing technology allows us to analyze geno-
me-wide expression patterns and epigenetic modiﬁcations in each
cell type. These analyses have demonstrated that different types of
cells have unique patterns of epigenetic modiﬁcations and that these
patterns are established as stem cells differentiate into each lineage
(Jepsen et al., 2007; Park et al., 2014; Ramos et al., 2015; Wapinski et
al., 2013; Wu et al., 2010). Although these studies have revealed
signiﬁcant epigenetic modiﬁcations regulating differentiation of NSCs,
we do not yet know how these unique patterns are established in
speciﬁc gene promoters or indeed how much they are involved in
stem cell differentiation.
We introduced above several examples of epigenetic modiﬁcation
changes in speciﬁc gene promoters that are induced by transcription
factors via blocking and recruiting epigeneticmodiﬁcation enzymes to
their cognate loci. However, the afﬁnity of transcription factors for the
loci themselves is also inﬂuenced by epigenetic modiﬁcations
(Takizawa et al., 2001; Wapinski et al., 2013). Thus, it is plausible
that the unique epigenetic modiﬁcation patterns established in each
gene locus or cell type are governed by the interplay between
multiple transcription factors and epigenetic modiﬁcation enzymes.
Recently, advanced genome-editing systems, such as the TALEN and
CRISPR-Cas9 systems, have been developed (Doudna and Charpentier,
2014; Hsu et al., 2014; Vasileva et al., 2015). We believe that, by using
these systems, we will be able to alter the epigenetic states of speciﬁc
sites in the genome, without changing DNA sequences to manipulate
the cell's behavior (Kearns et al., 2015; Mendenhall et al., 2013).Acknowledgements
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